ABIONYX Pharma SA (GB:0RAG)
LSE:0RAG

ABIONYX Pharma SA (0RAG) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
3Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
ABIONYX Pharma SA’s (0RAG) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting ABIONYX Pharma SA is a Buy.
ABIONYX Pharma SA’s (0RAG) 20-Day exponential moving average is 1.24, while ABIONYX Pharma SA’s (0RAG) share price is €1.25, making it a Buy.
ABIONYX Pharma SA’s (0RAG) 50-Day exponential moving average is 1.22, while ABIONYX Pharma SA’s (0RAG) share price is €1.25, making it a Buy.

ABIONYX Pharma SA (0RAG) Pivot Points

Jul 25, 2024, 04:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.24
1.24
1.24
1.24
1.24
1.24
1.24
Fibonacci
1.24
1.24
1.24
1.24
1.24
1.24
1.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ABIONYX Pharma SA (0RAG) Moving Averages

Jul 25, 2024, 04:24 PM
Period
Simple
Exponential
MA5
1.24Buy
1.24Buy
MA10
1.24Buy
1.24Buy
MA20
1.23Buy
1.24Buy
MA50
1.23Buy
1.22Buy
MA100
1.13Buy
1.19Buy
MA200
1.19Buy
1.20Buy
ABIONYX Pharma SA’s (0RAG) 10-Day exponential moving average is 1.24, while ABIONYX Pharma SA’s (0RAG) share price is €1.25, making it a Buy.
ABIONYX Pharma SA’s (0RAG) 100-Day exponential moving average is 1.19, while ABIONYX Pharma SA’s (0RAG) share price is €1.25, making it a Buy.
ABIONYX Pharma SA’s (0RAG) stock price is €1.25 and ABIONYX Pharma SA’s (0RAG) 50-day simple moving average is 1.23, creating a Buy signal.
ABIONYX Pharma SA’s (0RAG) stock price is €1.25 and ABIONYX Pharma SA’s (0RAG) 100-day simple moving average is 1.13, creating a Buy signal.
ABIONYX Pharma SA’s (0RAG) stock price is €1.25 and ABIONYX Pharma SA’s (0RAG) 200-day simple moving average is 1.19, creating a Buy signal.

ABIONYX Pharma SA (0RAG) Technical Indicators

Jul 25, 2024, 04:24 PM
Name
Value
Implied Action
RSI (14)
56.61
Neutral
STOCH (9,6)
84.92
Sell
STOCHRSI (14)
89.74
Sell
MACD (12,26)
<0.01
Buy
ADX (14)
22.88
Neutral
Williams %R
0.00
-
CCI (14)
140.32
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
34.50
Neutral
ROC
1.63
Buy
ABIONYX Pharma SA’s (0RAG) Relative Strength Index (RSI) is 56.61, creating a Neutral signal.
ABIONYX Pharma SA’s (0RAG) Trend Strength Indicator (ADX) is 22.88, creating a Neutral signal.
ABIONYX Pharma SA’s (0RAG) Commodity Channel Index (CCI) is 140.32, creating a Sell signal.
ABIONYX Pharma SA’s (0RAG) Price Rate of Change (ROC) is 1.63, creating a Buy signal.

FAQ

Is 0RAG a Buy, Hold, or Sell?
Based on 0RAG’s technical indicators, 0RAG is a Strong Buy.
    What is 0RAG’s RSI (14)?
    0RAG’s RSI (14) is 56.61, which suggests 0RAG is a Neutral.
      What is 0RAG’s MACD?
      0RAG’s MACD is <0.01, which suggests 0RAG is a Buy.
        What is 0RAG’s 5-day moving average?
        0RAG’s 5-day moving average is 1.24, which suggests 0RAG is a Buy.
          What is 0RAG’s 20-day moving average?
          0RAG 20-day moving average is 1.23, which suggests 0RAG is a Buy.
            What is 0RAG’s 50-day moving average?
            0RAG’s 50-day moving average is 1.23, which suggests 0RAG is a Buy.
              What is 0RAG’s 200-day moving average?
              0RAG’s 200-day moving average is 1.19, which suggests 0RAG is a Buy.
                What is 0RAG’s Williams % R (14)?
                Currently, no data Available
                What is 0RAG’s CCI (14)?
                0RAG’s CCI (14) is 140.32, which suggests 0RAG is a Sell.
                  What is the share price of ABIONYX Pharma SA?
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis